P. aeruginosa was highly prevalent among patients with VAP and HAP in mainland China. The initial empirical treatment of these patients remains challenging because of the strikingly high prevalence of antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: